Primerica Reports Second Quarter 2024 Results
Primerica reported robust results for the second quarter of 2024. The company saw a 14% increase in new life licenses, reaching 145,789 representatives. Term Life net premiums rose by 4%, while adjusted direct premiums increased 5%. Primerica issued $33 billion in Term Life face amounts and held $951 billion in total in-force coverage. Investment and Savings Products (ISP) sales surged by 29% to $3.1 billion, with client asset values up 15% to a record $105 billion.
GAAP diluted EPS was $0.03, with adjusted EPS at $4.71. The company declared a 20% dividend increase to $0.90 per share, payable on September 12, 2024, and repurchased $143 million in common stock. Total revenue increased 17% year-over-year to $803.4 million, while adjusted operating revenue rose 9% to $753.3 million. The exit from the Senior Health business impacted GAAP earnings but contributed to a 12% increase in adjusted net operating income to $162.7 million.
Strong sales of investment products, rising client asset values, and steady premium growth drove positive results despite some weakness in the Senior Health segment.
Primerica ha riportato risultati robusti per il secondo trimestre del 2024. L'azienda ha registrato un aumento del 14% nelle nuove licenze vita, raggiungendo 145.789 rappresentanti. I premi netti della Vita Temporanea sono aumentati del 4%, mentre i premi diretti rettificati sono saliti del 5%. Primerica ha emesso $33 miliardi in importi nominali di Vita Temporanea e detiene $951 miliardi in copertura totale in corso. Le vendite di Prodotti di Investimento e Risparmio (ISP) sono aumentate del 29%, raggiungendo $3,1 miliardi, con i valori degli asset dei clienti in aumento del 15%, per un totale record di $105 miliardi.
GAAP EPS diluito era di $0,03, con un EPS rettificato a $4,71. L'azienda ha dichiarato un aumento del dividendo del 20% a $0,90 per azione, pagabile il 12 settembre 2024, e ha riacquistato $143 milioni in azioni ordinarie. Il totale dei ricavi è aumentato del 17% anno su anno a $803,4 milioni, mentre i ricavi operativi rettificati sono saliti del 9% a $753,3 milioni. L'uscita dal settore della Salute Seniores ha impattato gli utili GAAP, ma ha contribuito a un aumento del 12% nel reddito operativo netto rettificato, arrivando a $162,7 milioni.
Forti vendite di prodotti di investimento, crescita dei valori degli asset dei clienti e un costante aumento dei premi hanno guidato risultati positivi nonostante alcune debolezze nel segmento della Salute Seniores.
Primerica reportó resultados sólidos para el segundo trimestre de 2024. La compañía vio un aumento del 14% en nuevas licencias de vida, alcanzando 145,789 representantes. Las primas netas de Vida Temporal crecieron un 4%, mientras que las primas directas ajustadas aumentaron un 5%. Primerica emitió $33 mil millones en montos de cobertura de Vida Temporal y posee $951 mil millones en cobertura total vigente. Las ventas de Productos de Inversión y Ahorro (ISP) se dispararon un 29%, alcanzando $3.1 mil millones, con los valores de los activos de los clientes en aumento del 15%, alcanzando un récord de $105 mil millones.
El EPS diluido GAAP fue de $0.03, con un EPS ajustado de $4.71. La empresa declaró un aumento del dividendo del 20% a $0.90 por acción, pagadero el 12 de septiembre de 2024, y recompró $143 millones en acciones ordinarias. Los ingresos totales aumentaron un 17% año tras año, alcanzando $803.4 millones, mientras que los ingresos operativos ajustados crecieron un 9% a $753.3 millones. La salida del negocio de Salud Senior impactó las ganancias GAAP, pero contribuyó a un aumento del 12% en el ingreso operativo neto ajustado a $162.7 millones.
Fuertes ventas de productos de inversión, aumento de los valores de los activos de los clientes y un crecimiento continuo de las primas impulsaron resultados positivos a pesar de algunas debilidades en el segmento de Salud Senior.
프라이머리카는 2024년 2분기 강력한 실적을 발표했습니다. 회사는 신규 생명 라이선스에서 14% 증가하여 145,789명의 대표를 확보했습니다. 상해생명 순보험료는 4% 증가했으며, 조정된 직접 보험료는 5% 증가했습니다. 프라이머리카는 330억 달러의 상해생명 펀드 구조를 발행했고, 총 9,510억 달러의 유효 보험 가입을 보유하고 있습니다. 투자 및 저축 제품 (ISP) 판매는 29% 증가하여 31억 달러에 도달했으며, 고객 자산 가치는 15% 증가하여 기록적인 1,050억 달러에 이르렀습니다.
GAAP 희석 EPS는 0.03달러였으며, 조정된 EPS는 4.71달러입니다. 회사는 주당 0.90달러의 배당금을 20% 인상한다고 발표했으며, 이는 2024년 9월 12일에 지급될 예정입니다. 또한 1억 4,300만 달러의 일반 주식을 재매입했습니다. 총 수익은 지난해 대비 17% 증가하여 8억 4,340만 달러에 도달했으며, 조정된 운영 수익은 9% 증가하여 7억 5,330만 달러에 이르렀습니다. 시니어 건강 사업에서의 퇴출은 GAAP 수익에 영향을 미쳤으나 조정된 순 운영 수익은 12% 증가하여 1억 6,270만 달러에 도달했습니다.
투자 제품의 강력한 판매, 증가하는 고객 자산 가치, 지속적인 보험료 성장은 시니어 건강 부문의 일부 약점에도 불구하고 긍정적인 결과를 이끌어냈습니다.
Primerica a annoncé des résultats robustes pour le deuxième trimestre de 2024. L'entreprise a connu une augmentation de 14 % des nouvelles licences de vie, atteignant 145 789 représentants. Les primes nettes d'assurance temporaire ont augmenté de 4 %, tandis que les primes directes ajustées ont connu une hausse de 5 %. Primerica a émis 33 milliards de dollars en montants de face d'assurance temporaire et détient un total de 951 milliards de dollars en couverture en cours. Les ventes de produits d'investissement et d'épargne (ISP) ont bondi de 29 % à 3,1 milliards de dollars, avec des valeurs d'actifs client en hausse de 15 %, atteignant un record de 105 milliards de dollars.
Le BPA dilué selon les normes GAAP était de 0,03 $, avec un BPA ajusté à 4,71 $. L'entreprise a annoncé une augmentation de dividende de 20 % à 0,90 $ par action, payable le 12 septembre 2024, et a racheté pour 143 millions de dollars d'actions ordinaires. Le chiffre d'affaires total a augmenté de 17 % d'une année sur l'autre, atteignant 803,4 millions de dollars, tandis que le chiffre d'affaires opérationnel ajusté a augmenté de 9 % pour atteindre 753,3 millions de dollars. Le retrait du secteur de la santé des seniors a eu un impact sur les bénéfices GAAP, mais a contribué à une augmentation de 12 % du revenu net d'exploitation ajusté, atteignant 162,7 millions de dollars.
Des ventes solides de produits d'investissement, une augmentation des valeurs d'actifs des clients et une croissance régulière des primes ont permis d'obtenir des résultats positifs malgré certaines faiblesses dans le segment de la santé des seniors.
Primerica berichtete über starke Ergebnisse im zweiten Quartal 2024. Das Unternehmen verzeichnete einen Anstieg von 14% bei neuen Lebenslizenzen und erreichte 145.789 Vertreter. Die Nettoprämien für Risikolebensversicherungen stiegen um 4%, während die bereinigten direkten Prämien um 5% zunahmen. Primerica gab 33 Milliarden Dollar in Risikoleben-Aushändigungen aus und hielt 951 Milliarden Dollar an bestehendem Versicherungsschutz. Die Verkäufe von Investitions- und Sparprodukten (ISP) stiegen um 29% auf 3,1 Milliarden Dollar, und die Vermögenswerte der Kundenkredite nahmen um 15% auf einen Rekordwert von 105 Milliarden Dollar zu.
GAAP verwässertes EPS betrug 0,03 Dollar, das bereinigte EPS lag bei 4,71 Dollar. Das Unternehmen kündigte eine Dividendenerhöhung um 20% auf 0,90 Dollar pro Aktie an, zahlbar am 12. September 2024, und hat Aktien im Wert von 143 Millionen Dollar zurückgekauft. Der Gesamtertrag stieg im Vergleich zum Vorjahr um 17% auf 803,4 Millionen Dollar, während die bereinigten Betriebseinnahmen um 9% auf 753,3 Millionen Dollar anstiegen. Der Austritt aus dem Geschäftsbereich Senioren Gesundheit beeinflusste die GAAP-Gewinne, trug jedoch zu einem Anstieg des bereinigten Netto-Betriebsergebnisses um 12% auf 162,7 Millionen Dollar bei.
Starke Verkäufe von Investmentprodukten, steigende Kundenvermögenswerte und ein stetiges Prämienwachstum führten trotz einiger Schwächen im Senior Health-Segment zu positiven Ergebnissen.
- 14% increase in new life licenses.
- Term Life net premiums up 4%; adjusted direct premiums up 5%.
- Investment and Savings Products sales up 29%.
- Client asset values up 15% to $105 billion.
- GAAP diluted EPS of $0.03; adjusted EPS of $4.71.
- Declared 20% dividend increase to $0.90 per share.
- Repurchased $143 million in common stock.
- Total revenue increased 17% to $803.4 million.
- Exit from Senior Health business impacted GAAP earnings.
- Senior Health revenues fell by 17%.
Insights
Primerica's Q2 2024 results show strong performance in core business segments despite challenges. Adjusted net operating income increased 12% to
Key highlights include:
- Term Life net premiums up
4% , with adjusted direct premiums rising5% - Investment and Savings Products sales surged
29% to$3.1 billion - Life-licensed sales force grew
6% to a record 145,789 representatives - Declared a
20% dividend increase to$0.90 per share
The company's core businesses are performing well, with strong growth in distribution and product sales. However, the Senior Health segment continues to face challenges, reporting an adjusted operating loss of
Primerica's Q2 results reflect resilience in a challenging economic environment. The
The
However, the elevated lapse rates in the Term Life segment, attributed to cost of living pressures, highlight ongoing challenges for middle-income families. This could be a broader indicator of financial stress among consumers, potentially impacting various sectors of the economy.
The company's decision to exit the underperforming Senior Health business demonstrates a strategic focus on core strengths, a trend we might see more of in the financial services industry as companies optimize their portfolios in response to market conditions.
Primerica's Q2 2024 report includes several legal and regulatory considerations worth noting:
- The exit from the Senior Health business involves significant non-cash adjustments, including goodwill and intangible asset write-offs. This process must be carefully managed to ensure compliance with accounting standards and proper disclosure to investors.
- The
$50 million in proceeds from an insurance claim related to the e-TeleQuote acquisition highlights the importance of representation and warranty insurance in M&A transactions. This successful claim demonstrates the value of such protections in mitigating acquisition risks. - The
20% dividend increase to$0.90 per share requires careful consideration of the company's financial position and future cash flows to ensure compliance with dividend regulations and maintain financial stability. - The estimated 445% RBC ratio for Primerica Life Insurance Company indicates strong capitalization, which is important for regulatory compliance and financial stability in the insurance industry.
These factors demonstrate Primerica's proactive approach to legal and regulatory matters, which is essential in the highly regulated financial services industry.
New life licenses up
Term Life net premiums increased
Issued Term Life face amount of
Investment and Savings Products sales of
Investment and Savings Products client asset values up
GAAP diluted earnings per share of
Declared a
The Company’s decision to exit the Senior Health business led to several non-cash adjustments in the second quarter of 2024. These included write-offs of the remaining goodwill and intangibles and the recognition of a tax benefit from the removal of the deferred tax liabilities associated with the intangible assets and a valuation allowance for state net operating losses. The quarter’s results also included income recognized from the receipt of cash proceeds paid under a previously disclosed insurance claim. The Company excluded these non-recurring items from adjusted operating results to provide a comparable basis to the prior period results. A reconciliation of these items to GAAP results is included in the tables at the end of this release.
Second quarter operating results were driven by strong sales of investment products and rising client asset values as well as steady premium growth and the predictable margins of the Term Life business. Investment income benefited from higher yielding investments and growth in the Company’s invested asset portfolio. Results were partially offset by weakness in the Senior Health business. Distribution results were strong during the quarter, driven by recruiting and growth in new life-licensed representatives.
“I am pleased with the continued momentum of our business and the ongoing efforts of our sales force to educate clients and help them navigate these uncertain times,” said Glenn Williams, Chief Executive Officer of Primerica, Inc. “We welcomed nearly 40,000 teammates during our international convention in July and believe the event will build momentum for the future.”
Second Quarter Distribution & Segment Results |
||||||||
Distribution Results |
||||||||
|
Q2 2024 |
Q2 2023 |
% Change |
|||||
Life-Licensed Sales Force |
|
145,789 |
|
137,806 |
6 |
% |
||
Recruits |
|
96,563 |
|
86,124 |
12 |
% |
||
New Life-Licensed Representatives |
|
14,402 |
|
12,638 |
14 |
% |
||
Life Insurance Policies Issued |
|
100,768 |
|
96,953 |
4 |
% |
||
Life Productivity (1) |
|
0.23 |
|
0.24 |
* |
|||
Issued Term Life Face Amount ($ billions) (2) |
$ |
33.2 |
$ |
32.2 |
3 |
% |
||
ISP Product Sales ($ billions) |
$ |
3.1 |
$ |
2.4 |
29 |
% |
||
Average Client Asset Values ($ billions) |
$ |
103.0 |
$ |
88.8 |
16 |
% |
||
Senior Health Submitted Policies (3) |
|
15,767 |
|
13,885 |
14 |
% |
||
Senior Health Approved Policies (4) |
|
14,646 |
|
12,915 |
13 |
% |
||
Closed |
$ |
99.6 |
$ |
82.2 |
21 |
% |
_______________________ | ||
(1) | Life productivity equals the average monthly policies issued divided by the average number of life insurance licensed representatives. |
|
(2) | Includes face amount on issued term life policies, additional riders added to existing policies, and face increases under increasing benefit riders. |
|
(3) | Represents the number of completed applications that, with respect to each such application, the applicant has authorized us to submit to the health insurance carrier. |
|
(4) | Represents an estimate of submitted policies approved by health insurance carriers during the indicated period. Not all approved policies will go in force. |
|
* Not calculated |
||
Segment Results |
||||||||||
|
Q2 2024 |
Q2 2023 |
% Change |
|||||||
|
($ in thousands) |
|||||||||
Adjusted Operating Revenues: |
|
|
|
|||||||
Term Life Insurance |
$ |
426,944 |
|
$ |
411,873 |
|
4 |
% |
||
Investment and Savings Products |
|
260,906 |
|
|
214,509 |
|
22 |
% |
||
Senior Health |
|
12,420 |
|
|
14,890 |
|
(17 |
)% |
||
Corporate and Other Distributed Products (1) |
|
53,015 |
|
|
48,293 |
|
10 |
% |
||
Total adjusted operating revenues (1) |
$ |
753,285 |
|
$ |
689,565 |
|
9 |
% |
||
|
|
|
|
|||||||
Adjusted Operating Income (Loss) before income taxes: |
|
|
|
|||||||
Term Life Insurance |
$ |
147,779 |
|
$ |
140,113 |
|
5 |
% |
||
Investment and Savings Products |
|
74,782 |
|
|
59,583 |
|
26 |
% |
||
Senior Health (1) |
|
(11,365 |
) |
|
(6,032 |
) |
88 |
% |
||
Corporate and Other Distributed Products (1) |
|
942 |
|
|
(3,588 |
) |
NM |
|
||
Total adjusted operating income before income taxes (1) |
$ |
212,138 |
|
$ |
190,076 |
|
12 |
% |
_________________________ | ||
(1) | See the Non-GAAP Financial Measures section and the Adjusted Operating Results reconciliation tables at the end of this release for additional information. |
|
Life Insurance Licensed Sales Force
During the second quarter, the Company successfully leveraged the excitement leading into its convention and the efforts of its field leaders to help new recruits effectively navigate the licensing process. The appeal of Primerica’s business opportunity continued to generate significant interest. The Company recruited a total of 96,563 individuals, a
Term Life Insurance
Life insurance policies issued during the second quarter increased
During the second quarter, Term Life revenues of
Investment and Savings Products
Total product sales during the quarter were
Second quarter ISP revenues of
Senior Health
During the second quarter of 2024, a total of 14,646 policies were approved by carriers, representing a
Second quarter Senior Health revenues were
Corporate and Other Distributed Products
During the second quarter of 2024, the segment recorded pre-tax adjusted operating income of
Taxes
The effective tax rate was
Capital
The Company repurchased 629,378 shares of common stock for
Non-GAAP Financial Measures
In addition to reporting financial results in accordance with
Adjusted direct premiums and other ceded premiums are net of amounts ceded under coinsurance transactions that were executed concurrent with our initial public offering (the “IPO coinsurance transactions”) for all periods presented. We exclude amounts ceded under the IPO coinsurance transactions in measuring adjusted direct premiums and other ceded premiums to present meaningful comparisons of the actual premiums economically maintained by the Company. Amounts ceded under the IPO coinsurance transactions will continue to decline over time as policies terminate within this block of business.
Adjusted operating revenues, adjusted operating income before income taxes, adjusted net operating income and diluted adjusted operating earnings per share exclude the impact of investment gains (losses), including credit impairments, and fair value mark-to-market (“MTM”) investment adjustments for all periods presented. We exclude investment gains (losses), including credit impairments, and MTM investment adjustments in measuring these non-GAAP financial measures to eliminate period-over-period fluctuations that may obscure comparisons of operating results due to items such as the timing of recognizing gains (losses) and market pricing variations prior to an invested asset’s maturity or sale that are not directly associated with the Company’s insurance operations. Also excluded from these non-GAAP financial measures is the receipt of insurance proceeds under a Representation and Warranty policy negotiated and purchased in connection with the acquisition of e-TeleQuote. We exclude this gain from our non-GAAP financial measures as it represents a non-recurring item that causes incomparability in the Company’s results.
Adjusted operating income before taxes, adjusted net operating income, and diluted adjusted operating earnings per share also exclude non-cash goodwill and intangible asset impairment charges. We exclude non-cash goodwill and intangible asset impairment charges as non-recurring items that cause incomparability between period-over-period results. Also excluded from these non-GAAP financial measures is restructuring and related charges incurred with the exit of our senior health business. We exclude these items from our non-GAAP financial measures as they are not useful in evaluating the Company’s ongoing operations. Adjusted net operating income and diluted adjusted operating earnings per share also exclude the tax effect of pre-tax operating adjustments, the deferred tax benefit recognized in association with the impairment of intangible assets and the valuation allowance recognized for state operating losses in the Company’s Senior Health segment. We exclude these items from our non-GAAP financial measures as they represent the tax effect of pre-tax operating adjustments and/or non-recurring items that will cause incomparability between period-over-period results.
Our definitions of these non-GAAP financial measures may differ from the definitions of similar measures used by other companies. Management uses these non-GAAP financial measures in making financial, operating and planning decisions and in evaluating the Company’s performance. Furthermore, management believes that these non-GAAP financial measures may provide users with additional meaningful comparisons between current results and results of prior periods as they are expected to be reflective of the core ongoing business. These measures have limitations and users should not consider them in isolation or as a substitute for analysis of the Company’s results as reported under GAAP. Reconciliations of GAAP to non-GAAP financial measures are attached to this release.
Earnings Webcast Information
Primerica will hold a webcast on Thursday, August 8, 2024, at 10:00 a.m. Eastern, to discuss the quarter’s results. To access the webcast, go to https://investors.primerica.com at least 15 minutes prior to the event to register, download and install any necessary software. A replay of the call will be available for approximately 30 days. This release and a detailed financial supplement will be posted on Primerica’s website.
Forward-Looking Statements
Except for historical information contained in this press release, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements contain known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from anticipated or projected results. Those risks and uncertainties include, among others, our failure to continue to attract and license new recruits, retain sales representatives or license or maintain the licensing of sales representatives; new laws or regulations that could apply to our distribution model, which could require us to modify our distribution structure; changes to the independent contractor status of sales representatives; our or sales representatives’ violation of or non-compliance with laws and regulations; litigation and regulatory investigations and actions concerning us or sales representatives; differences between our actual experience and our expectations regarding mortality, persistency, disability or insurance as reflected in the pricing for our insurance policies; changes in federal, state and provincial legislation or regulation that affects our insurance, investment product and mortgage businesses; our failure to meet regulatory capital ratios or other minimum capital and surplus requirements; a significant downgrade by a ratings organization; the failure of our reinsurers or reserve financing counterparties to perform their obligations; the failure of our investment products to remain competitive with other investment options or the loss of our relationship with one or more of the companies whose investment products we provide; heightened standards of conduct or more stringent licensing requirements for sales representatives; inadequate policies and procedures regarding suitability review of client transactions; revocation of our subsidiary’s status as a non-bank custodian; inability to abandon our ownership of e-TeleQuote by the anticipated date, or at all, which would cause us to exit the senior health insurance distribution business by an alternative method that may not be as beneficial to stockholder value as the planned abandonment; a significant change to or disruption in the mortgage lenders’ mortgage businesses or an inability of the mortgage lenders to satisfy their contractual obligations to us; economic downcycles that impact our business, financial condition and results of operations; major public health pandemics, epidemics or outbreaks or other catastrophic events; the failure of our or a third-party partner’s information technology systems, breach of our information security, failure of our business continuity plan or the loss of the Internet; any failure to protect the confidentiality of client information; the current legislative and regulatory climate with regard to privacy and cybersecurity; cyber-attack(s), security breaches or if e-TeleQuote is otherwise unable to safeguard the security and privacy of confidential data, including personal health information; the effects of credit deterioration and interest rate fluctuations on our invested asset portfolio and other assets; incorrectly valuing our investments; changes in accounting standards may impact how we record and report our financial condition and results of operations; the inability of our subsidiaries to pay dividends or make distributions; litigation and regulatory investigations and actions; a significant change in the competitive environment in which we operate; the loss of key personnel or sales force leaders; the efficiency and success of business initiatives to enhance our technology, products and services; any acquisition or investment in businesses that do not perform as we expect or are difficult to integrate; and fluctuations in the market price of our common stock or Canadian currency exchange rates. These and other risks and uncertainties affecting us are more fully described in our filings with the Securities and Exchange Commission, which are available in the "Investor Relations" section of our website at https://investors.primerica.com. Primerica assumes no duty to update its forward-looking statements as of any future date.
About Primerica, Inc.
Primerica, Inc., headquartered in
PRIMERICA, INC. AND SUBSIDIARIES |
|||||||
Condensed Consolidated Balance Sheets |
|||||||
|
|||||||
|
(Unaudited) |
|
|||||
|
June 30, 2024 |
December 31, 2023 |
|||||
|
(In thousands) |
||||||
Assets |
|
|
|||||
Investments: |
|
|
|||||
Fixed-maturity securities available-for-sale, at fair value |
$ |
2,796,030 |
|
$ |
2,719,467 |
|
|
Fixed-maturity security held-to-maturity, at amortized cost |
|
1,353,370 |
|
|
1,386,980 |
|
|
Short-term investments available-for-sale, at fair value |
|
- |
|
|
276 |
|
|
Equity securities, at fair value |
|
26,026 |
|
|
29,680 |
|
|
Trading securities, at fair value |
|
3,158 |
|
|
18,383 |
|
|
Policy loans and other invested assets |
|
49,791 |
|
|
51,175 |
|
|
Total investments |
|
4,228,375 |
|
|
4,205,961 |
|
|
Cash and cash equivalents |
|
627,292 |
|
|
613,148 |
|
|
Accrued investment income |
|
25,687 |
|
|
23,958 |
|
|
Reinsurance recoverables |
|
2,833,055 |
|
|
3,015,777 |
|
|
Deferred policy acquisition costs, net |
|
3,566,126 |
|
|
3,447,234 |
|
|
Renewal commissions receivable |
|
171,022 |
|
|
190,258 |
|
|
Agent balances, due premiums and other receivables |
|
288,766 |
|
|
273,066 |
|
|
Goodwill |
|
- |
|
|
127,707 |
|
|
Intangible assets, net |
|
45,275 |
|
|
175,025 |
|
|
Income taxes |
|
118,379 |
|
|
123,514 |
|
|
Operating lease right-of-use assets |
|
50,646 |
|
|
53,693 |
|
|
Other assets |
|
357,115 |
|
|
382,549 |
|
|
Separate account assets |
|
2,253,966 |
|
|
2,395,842 |
|
|
Total assets |
$ |
14,565,704 |
|
$ |
15,027,732 |
|
|
|
|
|
|||||
Liabilities and Stockholders' Equity |
|
|
|||||
Liabilities: |
|
|
|||||
Future policy benefits |
$ |
6,436,332 |
|
$ |
6,742,025 |
|
|
Unearned and advance premiums |
|
17,076 |
|
|
14,876 |
|
|
Policy claims and other benefits payable |
|
478,773 |
|
|
513,803 |
|
|
Other policyholders' funds |
|
412,570 |
|
|
435,094 |
|
|
Note payable |
|
594,110 |
|
|
593,709 |
|
|
Surplus note |
|
1,353,014 |
|
|
1,386,592 |
|
|
Income taxes |
|
135,049 |
|
|
135,247 |
|
|
Operating lease liabilities |
|
58,756 |
|
|
61,358 |
|
|
Other liabilities |
|
613,303 |
|
|
583,434 |
|
|
Payable under securities lending |
|
90,995 |
|
|
99,785 |
|
|
Separate account liabilities |
|
2,253,966 |
|
|
2,395,842 |
|
|
Total liabilities |
|
12,443,944 |
|
|
12,961,765 |
|
|
|
|
|
|||||
Stockholders' equity |
|
|
|||||
|
|
|
|||||
Common stock |
|
340 |
|
|
350 |
|
|
Paid-in capital |
|
- |
|
|
- |
|
|
Retained earnings |
|
2,122,832 |
|
|
2,276,946 |
|
|
Accumulated other comprehensive income (loss), net of income tax: |
|
|
|||||
Effect of change in discount rate assumptions on the liability for future policy benefits |
|
201,441 |
|
|
(39,086 |
) |
|
Unrealized foreign currency translation gains (losses) |
|
(15,507 |
) |
|
(2,235 |
) |
|
Net unrealized gains (losses) on available-for-sale securities |
|
(187,346 |
) |
|
(170,008 |
) |
|
Total stockholders' equity |
|
2,121,760 |
|
|
2,065,967 |
|
|
Total liabilities and stockholders' equity |
$ |
14,565,704 |
|
$ |
15,027,732 |
|
|
PRIMERICA, INC. AND SUBSIDIARIES |
|||||||
Condensed Consolidated Statements of Income |
|||||||
(Unaudited) |
|||||||
|
|
|
|
||||
|
Three months ended June 30, |
||||||
|
2024 |
|
2023 |
||||
|
(In thousands, except per-share amounts) |
||||||
Revenues: |
|
|
|
||||
Direct premiums |
$ |
845,358 |
|
|
$ |
828,296 |
|
Ceded premiums |
|
(427,561 |
) |
|
|
(425,266 |
) |
Net premiums |
|
417,797 |
|
|
|
403,030 |
|
Commissions and fees |
|
279,769 |
|
|
|
233,130 |
|
Net investment income |
|
38,452 |
|
|
|
32,398 |
|
Investment gains (losses) |
|
(99 |
) |
|
|
(328 |
) |
Other, net |
|
67,456 |
|
|
|
20,155 |
|
Total revenues |
|
803,375 |
|
|
|
688,385 |
|
|
|
|
|
||||
Benefits and expenses: |
|
|
|
||||
Benefits and claims |
|
150,030 |
|
|
|
148,911 |
|
Future policy benefits remeasurement (gain) loss |
|
(4,329 |
) |
|
|
(1,867 |
) |
Amortization of deferred policy acquisition costs |
|
73,643 |
|
|
|
68,110 |
|
Sales commissions |
|
142,154 |
|
|
|
113,623 |
|
Insurance expenses |
|
62,685 |
|
|
|
59,093 |
|
Insurance commissions |
|
7,399 |
|
|
|
9,142 |
|
Contract acquisition costs |
|
15,724 |
|
|
|
12,602 |
|
Interest expense |
|
6,099 |
|
|
|
6,686 |
|
Impairment of goodwill and other long-lived assets (1) |
|
253,607 |
|
|
|
- |
|
Other operating expenses |
|
88,566 |
|
|
|
83,189 |
|
Total benefits and expenses |
|
795,578 |
|
|
|
499,489 |
|
Income before income taxes |
|
7,797 |
|
|
|
188,896 |
|
Income taxes |
|
6,626 |
|
|
|
44,392 |
|
Net income |
$ |
1,171 |
|
|
$ |
144,504 |
|
|
|
|
|
||||
Earnings per share: |
|
|
|
||||
Basic earnings per share |
$ |
0.03 |
|
|
$ |
3.97 |
|
Diluted earnings per share |
$ |
0.03 |
|
|
$ |
3.97 |
|
|
|
|
|
||||
Weighted-average shares used in computing earnings per share: |
|
|
|
||||
Basic |
|
34,383 |
|
|
|
36,215 |
|
Diluted |
|
34,383 |
|
|
|
36,290 |
|
(1) Other long-lived assets impairment consists of intangible assets ( |
|||||||
PRIMERICA, INC. AND SUBSIDIARIES |
||||||||||
Consolidated Adjusted Operating Results Reconciliation |
||||||||||
(Unaudited) |
||||||||||
|
|
|
|
|
|
|||||
|
Three months ended June 30, |
|
|
|||||||
|
2024 |
|
2023 |
|
% Change |
|||||
|
(In thousands, except per-share amounts) |
|
|
|||||||
Total revenues |
$ |
803,375 |
|
|
$ |
688,385 |
|
|
17 |
% |
Less: Investment (losses) gains |
|
(99 |
) |
|
|
(328 |
) |
|
|
|
Less: |
|
189 |
|
|
|
(852 |
) |
|
|
|
Less: Gain on insurance proceeds |
|
50,000 |
|
|
|
- |
|
|
|
|
Adjusted operating revenues |
$ |
753,285 |
|
|
$ |
689,565 |
|
|
9 |
% |
|
|
|
|
|
|
|||||
Income before income taxes |
$ |
7,797 |
|
|
$ |
188,896 |
|
|
NM |
|
Less: Investment (losses) gains |
|
(99 |
) |
|
|
(328 |
) |
|
|
|
Less: |
|
189 |
|
|
|
(852 |
) |
|
|
|
Less: Gain on insurance proceeds |
|
50,000 |
|
|
|
- |
|
|
|
|
Less: Restructuring costs |
|
(824 |
) |
|
|
- |
|
|
|
|
Less: Impairment of goodwill |
|
(127,707 |
) |
|
|
- |
|
|
|
|
Less: Impairment of other long-lived assets |
|
(125,900 |
) |
|
|
- |
|
|
|
|
Adjusted operating income before income taxes |
$ |
212,138 |
|
|
$ |
190,076 |
|
|
12 |
% |
|
|
|
|
|
|
|||||
Net income |
$ |
1,171 |
|
|
$ |
144,504 |
|
|
NM |
|
Less: Investment (losses) gains |
|
(99 |
) |
|
|
(328 |
) |
|
|
|
Less: |
|
189 |
|
|
|
(852 |
) |
|
|
|
Less: Gain on insurance proceeds |
|
50,000 |
|
|
|
- |
|
|
|
|
Less: Restructuring costs |
|
(824 |
) |
|
|
- |
|
|
|
|
Less: Impairment of goodwill |
|
(127,707 |
) |
|
|
- |
|
|
|
|
Less: Tax impact of preceding items |
|
18,720 |
|
|
|
277 |
|
|
|
|
Less: Impairment of other long-lived assets |
|
(125,900 |
) |
|
|
- |
|
|
|
|
Less: Deferred tax benefit of impairment of other long-lived assets |
|
35,126 |
|
|
|
- |
|
|
|
|
Less: Valuation allowance on Senior Health state net operating losses |
|
(11,080 |
) |
|
|
- |
|
|
|
|
Adjusted net operating income |
$ |
162,746 |
|
|
$ |
145,407 |
|
|
12 |
% |
|
|
|
|
|
|
|||||
Diluted earnings per share |
$ |
0.03 |
|
|
$ |
3.97 |
|
|
NM |
|
Less: Net after-tax impact of operating adjustments |
|
(4.68 |
) |
|
|
(0.02 |
) |
|
|
|
Diluted adjusted operating earnings per share |
$ |
4.71 |
|
|
$ |
3.99 |
|
|
18 |
% |
TERM LIFE INSURANCE SEGMENT |
||||||||||
Adjusted Premiums Reconciliation |
||||||||||
(Unaudited) |
||||||||||
|
|
|
|
|
|
|||||
|
Three months ended June 30, |
|
|
|||||||
|
2024 |
|
2023 |
|
% Change |
|||||
|
(In thousands) |
|
|
|||||||
Direct premiums |
$ |
840,668 |
|
|
$ |
823,297 |
|
|
2 |
% |
Less: Premiums ceded to IPO coinsurers |
|
201,566 |
|
|
|
216,740 |
|
|
|
|
Adjusted direct premiums |
|
639,102 |
|
|
|
606,557 |
|
|
5 |
% |
|
|
|
|
|
|
|||||
Ceded premiums |
|
(426,348 |
) |
|
|
(423,704 |
) |
|
|
|
Less: Premiums ceded to IPO coinsurers |
|
(201,566 |
) |
|
|
(216,740 |
) |
|
|
|
Other ceded premiums |
|
(224,782 |
) |
|
|
(206,964 |
) |
|
|
|
Net premiums |
$ |
414,320 |
|
|
$ |
399,593 |
|
|
4 |
% |
|
|
|
|
|
|
|
||||||||||
SENIOR HEALTH SEGMENT |
||||||||||
Adjusted Operating Results Reconciliation |
||||||||||
(Unaudited) |
||||||||||
|
||||||||||
|
Three months ended June 30, |
|
|
|||||||
|
2024 |
|
2023 |
|
% Change |
|||||
|
(In thousands) |
|
|
|||||||
Income (loss) before income taxes |
$ |
(264,972 |
) |
|
$ |
(6,032 |
) |
|
NM |
|
Less: Impairment of goodwill |
|
(127,707 |
) |
|
|
- |
|
|
|
|
Less: Impairment of other long-lived assets |
|
(125,900 |
) |
|
|
- |
|
|
|
|
Adjusted operating income (loss) before income taxes |
$ |
(11,365 |
) |
|
$ |
(6,032 |
) |
|
88 |
% |
|
|
|
|
|
|
|||||
CORPORATE AND OTHER DISTRIBUTED PRODUCTS SEGMENT |
||||||||||
Adjusted Operating Results Reconciliation |
||||||||||
(Unaudited) |
||||||||||
|
|
|
|
|
|
|||||
|
Three months ended June 30, |
|
|
|||||||
|
2024 |
|
2023 |
|
% Change |
|||||
|
(In thousands) |
|
|
|||||||
Total revenues |
$ |
103,105 |
|
|
$ |
47,113 |
|
|
NM |
|
Less: Investment gains (losses) |
|
(99 |
) |
|
|
(328 |
) |
|
|
|
Less: |
|
189 |
|
|
|
(852 |
) |
|
|
|
Less: Gain on insurance proceeds |
|
50,000 |
|
|
|
- |
|
|
|
|
Adjusted operating revenues |
$ |
53,015 |
|
|
$ |
48,293 |
|
|
10 |
% |
|
|
|
|
|
|
|||||
Income (loss) before income taxes |
$ |
50,208 |
|
|
$ |
(4,768 |
) |
|
NM |
|
Less: Investment gains (losses) |
|
(99 |
) |
|
|
(328 |
) |
|
|
|
Less: |
|
189 |
|
|
|
(852 |
) |
|
|
|
Less: Restructuring costs |
|
(824 |
) |
|
|
- |
|
|
|
|
Less: Gain on insurance proceeds |
|
50,000 |
|
|
|
- |
|
|
|
|
Adjusted operating income (loss) before income taxes |
$ |
942 |
|
|
$ |
(3,588 |
) |
|
NM |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20240807775409/en/
Investor Contact:
Nicole Russell
470-564-6663
Email: Nicole.Russell@primerica.com
Media Contact:
Susan Chana
404-229-8302
Email: Susan.Chana@Primerica.com
Source: Primerica, Inc.
FAQ
What were Primerica's earnings per share for Q2 2024?
How much did Primerica's Investment and Savings Products sales increase in Q2 2024?
What was Primerica's total revenue for Q2 2024?
How much did Primerica's client asset values grow in Q2 2024?
What was the impact of Primerica's exit from the Senior Health business?
How did Primerica's Term Life net premiums perform in Q2 2024?